We are live on ! Find out more
ENVB icon

Enveric Biosciences
ENVB

0 hedge funds and large institutions have $20K invested in Enveric Biosciences in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% less capital invested

Capital invested by funds: $90K → $20K (-$70K)

100% less funds holding

Funds holding: 1 → 0 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
–
Holders Change
-1
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$70K
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$2K
3
UBS Group
UBS Group
Switzerland
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
1
Geode Capital Management
Massachusetts
$14K – – –
Osaic Holdings
2
Osaic Holdings
Arizona
$6K – – –
VF
3
Virtu Financial
New York
– -$70K -1 Closed
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
– -$2K – –
UBS Group
5
UBS Group
Switzerland
– -$2K – –

ENVB Hedge Fund Activity: Q3 2020 in Review

0 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Enveric Biosciences (ENVB) for Q3 2020, worth a combined $20K — down 78% from $90K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of ENVB and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Virtu Financial, exiting entirely with an estimated $70K sold.

  • 0 institutional investors held Enveric Biosciences (ENVB) as of Q3 2020, down from 1 in Q2 2020.
  • Funds reported $20K of Enveric Biosciences stock for Q3 2020, down 78% quarter-over-quarter.
  • 0 funds opened new Enveric Biosciences positions in Q3 2020 and 1 closed out, a net change of -1 holder.
  • The largest Enveric Biosciences seller in Q3 2020 was Virtu Financial, an estimated $70K sold.

Based on aggregated 13F filings for Q3 2020.